Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...

From innovative gene therapies to cutting the lines of communication between cancer cells, researchers are devising advanced new therapies to combat the disease ...

In A Nutshell Among older adults carrying the APOE ε4 gene variant, the predominant genetic risk factor for Alzheimer’s ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma – – Licensed SYN-020 to ...

Cadence’s leadership in agentic AI is expanded by integrating portfolio of chip and system design solutions with NVIDIA’s ...

The MarketWatch News Department was not involved in the creation of this content.-- Mirion announces that its Crew Active Dosimeters (CAD) will be worn by astronauts on NASA's Art ...

Advancements in pharmacogenomics and multi-omics are transforming IBS care, enabling personalized treatment strategies based ...

Joining me today are Sean McClain, Absci Corporation’s Founder and CEO; Zach Jonasson, Chief Financial Officer and Chief ...

Healthcare professionals made higher-quality and more credible TikTok videos about sudden cardiac death, but non-healthcare creators attracted more reshares, favourites, and overall engagement.